While the pharmaceutical industry faces growing concerns over counterfeit and substandard medicines, Davipharm, a member of Adamed Group stands as a beacon of trust and high quality. The local drug manufacturer remains steadfast in its core strategy: delivering high-quality, affordable, and accessible medicines for Vietnam and beyond. With every milestone, Davipharm reaffirms that quality is not just a goal, but the foundation of its sustainable development.

Raising the bar for made-in-Vietnam medicines

At the heart of this commitment lies a series of groundbreaking achievements that have elevated Davipharm to the forefront of Vietnam’s pharmaceutical industry. In 2021, the company received EU-GMP certification for non-sterile products in capsules, hard-shells, and tablets.

In 2024, Davipharm became the first company in Vietnam and the Southeast Asian region to obtain EU-GMP certification for its High Potent (HP) Zone, a high-standard facility for manufacturing, among others, oncology drugs. The company’s new developments based on the technology transfers meet the strict requirements of the highly regulated markets, allowing to produce high-quality medicines not only for Vietnamese patients but also for export…

The momentum has continued in 2025, with the FDA Philippines re-certifying Davipharm as a GMP-compliant manufacturer, including both its standard and HP production lines. This certification paves the way for a diverse portfolio of Davipharm products to be registered and distributed in the Philippines.

This achievement marks a significant step forward in the company’s ambition to become Vietnam’s leading pharmaceutical exporter. As Davipharm expands its reach into the broader Southeast Asian market, the recognition by the Philippine regulator opens new business opportunities and reinforces its reputation as a trusted partner in the region.

Investing in global quality & people excellence

Even amid market fluctuations and rising cost pressures, Davipharm has never wavered in its dedication to quality and innovation. The company continues to invest in R&D, factory upgrades, and international market access, with additional certifications from the EAEU-GMP and SFDA-GMP (UAE) currently in progress.

These ongoing efforts reflect Davipharm’s determination to maintain the highest standards while enhancing its competitiveness on the global stage.

Internally, Davipharm has strengthened its compliance and continuous improvement through ongoing programs of Certified Auditors and Certified Investigators.

Led by Qualified Person of international standing, these programs deliver annual training to teams spanning Quality Assurance and Quality Control, Production, Packaging, R&D, Engineering, Supply Chain, Regulatory Affairs, Technology Transfer, and Data Integrity.

The Certified Investigator initiative, aligned with EU-GMP and WHO-GMP standards, is designed to deepen employees’ expertise and enhance their ability to investigate and resolve deviations effectively – ensuring both drug quality and patient safety.

Meanwhile, the Certified Auditor program equips GMP auditors with advanced knowledge and practical insights gained from internal and external audits in Vietnam, India, and China. Participants discuss audit advantages, common challenges, and propose improvements for the coming year, fostering a dynamic learning environment. The program also identifies and certifies dozens of the most outstanding auditors and investigators across the organization.

Unwavering commitment to patients and partners

With these initiatives, Davipharm demonstrates that quality is more than a standard – it is a mindset embedded in every process, every team, and every decision.

The company remains agile in a dynamic market by driving Kaizen improvements, embracing breakthrough solutions, and strengthening partnerships, all while staying true to its vision: delivering high quality products and services at affordable prices to elevate the image of made in Vietnam medicines; as well as supplying products to local and international markets.

As counterfeit drugs and inconsistent quality continue to challenge public trust in Vietnam, Davipharm’s unwavering commitment to quality can lead to success – building a sustainable business on a foundation of global standards and unshakable trust.

Source: https://thuonghieucongluan-com-vn.translate.goog/davipharm-phat-trien-ben-vung-bang-uy-tin-chat-luong-a271425.html?_x_tr_sl=vi&_x_tr_tl=en&_x_tr_hl=vi&_x_tr_pto=wapp